Your symptoms are real. Your exhaustion has biological drivers. And recovery can be measured.
Why Long COVID and Post-Acute Sequelae Persist for Months or Years
When people develop long COVID, they often wonder why symptoms persist long after the initial infection has cleared.
Long COVID, also called long haul COVID, chronic COVID, post-COVID syndrome, or post-acute sequelae of COVID-19, is defined as a post-infection condition where symptoms persist for three months or more after the initial COVID-19 illness. It is characterized by a wide range of symptoms that can last for weeks, months, or even years after the initial infection. Common symptoms include fatigue, brain fog, shortness of breath, chest pain, joint pain, and neurological issues. Long COVID can affect anyone who has had COVID-19, including those who were asymptomatic during their initial infection, and it is not contagious. The prevalence of long COVID is estimated to be about 6–7% in adults and about 1% in children. Hypotheses for the causes of long COVID include lasting damage to organs and blood vessels, problems with blood clotting, neurological dysfunction, persistent virus, reactivation of latent viruses, and autoimmunity. While organ damage from the acute infection can explain some symptoms, long COVID is also observed in people without apparent organ damage.
The World Health Organization defines this infection associated chronic condition as symptoms lasting at least three months after acute covid infection, affecting an estimated 10-20% of those who contract SARS-CoV-2. Understanding the underlying mechanisms helps explain why standard treatments often fall short.
Viral fragments remain in tissues and the bloodstream for months after the initial illness resolves. These persistent viral proteins trigger ongoing immune system activation, creating a self-perpetuating cycle of long COVID inflammation that affects multiple organ systems. Your body continues fighting an enemy that conventional tests no longer detect.
Inflammatory proteins accumulate in the bloodstream, driving immune dysregulation that prevents normal healing. Elevated cytokines like IL-6 and TNF-alpha sustain a pro-inflammatory state, contributing to the persistent symptoms that define post covid conditions. This chronic inflammation becomes a systemic disease state affecting everything from cognitive function to cardiovascular health.
Microclots—tiny blood clots resistant to the body’s normal clot-dissolving mechanisms—block oxygen delivery to tissues throughout the body. These amyloid-like fibrin formations contribute to tissue hypoxia, explaining why many people with long COVID experience difficulty breathing, chest pain, and severe fatigue despite normal-appearing standard blood tests.
Mitochondrial dysfunction compounds these problems, impairing cellular energy production at the most fundamental level. When your cells cannot generate adequate ATP, chronic fatigue after COVID becomes inevitable. This explains why physical or mental activity often triggers post exertional malaise—your cellular power plants simply cannot meet demand.
Autonomic nervous system disruption affects heart rate regulation, blood pressure, digestion, and temperature control. Many patients develop postural orthostatic tachycardia syndrome (POTS), experiencing dizziness and rapid heartbeat upon standing. These neurological symptoms reflect broader disruption of the body’s automatic control systems.
What is EBOO Therapy and How Does It Support Healing
EBOO therapy—Extracorporeal Blood Oxygenation and Ozonation—represents an advanced oxidative therapy for viral illness that addresses multiple drivers of post viral syndrome simultaneously. This treatment draws approximately 200-300 mL of blood, processes it through specialized filtration, enhances oxygenation, and returns it to circulation.
The blood filtration component removes inflammatory proteins, toxins, and particulates including potential microclots that contribute to long term symptoms. This dialysis-like process extracts cytokines, immune complexes, and debris that perpetuate the inflammatory cascade. For people with long COVID struggling to regain function, this filtration addresses root causes rather than merely masking symptoms.
The oxygenation process infuses medical-grade oxygen and carefully controlled ozone (O3) into the blood. This hyperoxic treatment surpasses what hyperbaric oxygen therapy alone can achieve by directly enriching plasma-dissolved oxygen. Enhanced oxygen delivery supports tissue healing throughout the body.
Ozone therapy provides antimicrobial effects through ozonide production while modulating redox signaling and upregulating antioxidant enzymes like superoxide dismutase. This supports immune function without the immunosuppression that many conventional approaches require. Each session typically lasts 45-60 minutes in a comfortable clinical setting.
The safety profile of EBOO therapy reflects decades of European clinical experience with oxidative protocols. Contraindications include G6PD deficiency and acute instability, requiring proper screening before treatment. EBOO does not replace conventional medical care but rather complements it as part of comprehensive long COVID treatment approaches.
Micro-clots, Inflammation and Viral Fragments — “The Hidden Drivers”
Research into microclots long COVID has revealed why so many patients receive normal results on standard blood tests yet remain profoundly ill. These microscopic clots resist the body’s fibrinolytic processes, persisting in circulation and obstructing microvascular flow. Specialized testing reveals what conventional labs miss.
The spike protein and other viral fragments persist in tissues long after acute infection resolves. These fragments act as persistent antigens, fueling immune overactivation and contributing to autoimmune phenomena. Healthcare providers unfamiliar with these mechanisms may dismiss ongoing symptoms as psychological—but the biology tells a different story.
The cytokine storm aftermath creates lasting health problems throughout multiple organ systems. Elevated inflammatory markers sustain tissue damage and prevent normal repair processes. This explains why many long haul covid patients experience new symptoms or worsening of underlying health conditions months after apparent recovery.
Endothelial dysfunction—damage to the cells lining blood vessels—impairs circulation and contributes to blood clots at both macro and micro levels. This vascular injury underlies many cardiovascular, neurological, and respiratory symptoms that define post covid syndrome. Damaged blood vessels cannot deliver adequate oxygen regardless of lung function.
Standard laboratory panels were not designed to detect these abnormalities. Specialized testing for D-dimer, fibrinogen, inflammatory cytokine panels, and microclot visualization provides diagnostic clarity that routine bloodwork cannot. This explains the frustrating disconnect between severe symptoms and “normal” test results that many patients experience.
How EBOO Oxygenates the Blood and Filters Inflammatory Proteins
Understanding the step-by-step EBOO treatment process helps patients know what to expect and how each phase supports recovery from post viral fatigue syndrome.
Blood Extraction: A small IV catheter provides venous access, allowing blood to flow into the EBOO system. This phase uses standard phlebotomy techniques with continuous monitoring of hemodynamic stability throughout the procedure.
Filtration Phase: Blood passes through a specialized dialysis-like filter that removes inflammatory cytokines, fibrinogen aggregates, C-reactive protein, and other inflammatory proteins. This physical removal addresses long COVID inflammation at its source, extracting the molecular drivers of chronic infection detox therapy needs.
Oxygenation and Ozonation: The filtered blood receives infusion of medical-grade oxygen and precisely controlled ozone concentrations. This creates hyperoxic conditions that enhance oxygen-carrying capacity, support antimicrobial activity, and promote antioxidant enzyme upregulation. The process induces beneficial ozonides without tissue damage.
Return to Circulation: Oxygenated, filtered blood returns to the patient’s venous system. The body immediately benefits from enhanced oxygen delivery and reduced inflammatory burden. Patients often notice warmth or mild tingling during this phase.
Treatment frequency typically involves 6-12 sessions spaced weekly, with cumulative benefits emerging over the treatment course. Many patients report gradual energy gains and symptom reduction without significant downtime between sessions.
Why EBOO May Help Epstein-Barr Virus Reactivation
The connection between COVID-19 and Epstein Barr virus reactivation represents a significant factor in why some patients develop long COVID with particularly severe and persistent symptoms. Immune system suppression during acute infection allows dormant viruses like EBV to reactivate, creating additional chronic infection burden.
Serological studies show elevated EBV IgG titers in many long COVID patients, linking reactivation to chronic fatigue, joint pain, and neurological symptoms. EBV drives B-cell proliferation and can trigger cross-reactive autoimmunity that mimics or exacerbates post acute sequelae. This viral reactivation often goes unrecognized by primary care physicians unfamiliar with its role in post-viral illness.
EBOO’s potential relevance to EBV reactivation stems from multiple mechanisms. Ozone demonstrates virucidal properties that can disrupt EBV glycoproteins, while filtration removes EBV-infected cell debris and immune complexes from circulation. The systemic anti-inflammatory effects help mitigate EBV fatigue and joint pain that many patients experience.
Clinical observations suggest that addressing EBV reactivation as part of comprehensive long COVID treatment improves outcomes for patients with confirmed reactivation per serology. The immune dysregulation support provided by EBOO helps restore balanced immune function rather than simply suppressing symptoms.
Long COVID Symptoms Our Patients Frequently Report Improvement In
The common symptoms of long COVID affect virtually every organ system, creating complex clinical pictures that vary significantly between individuals. Long COVID symptoms can include respiratory, neurological (such as difficulty concentrating), cardiac, and psychological problems. In addition to fatigue and brain fog, other long COVID symptoms may include joint pain, muscle pain, hair loss, skin rashes, and metabolic disturbances. Understanding which symptoms may respond to EBOO therapy helps patients and healthcare providers make informed decisions about treatment approaches.
Severe Fatigue and Post-Exertional Malaise
Post exertional malaise—where symptoms worsen 12 to 48 hours after physical or mental activity—represents one of the most disabling features of long haul covid. Patients frequently report that EBOO’s enhanced oxygen delivery and mitochondrial support helps restore energy production capacity. Reduced lactate buildup during exertion suggests improved cellular metabolism.
The chronic fatigue that defines post viral syndrome stems from impaired ATP production at the cellular level. EBOO addresses this through enhanced oxygenation supporting mitochondrial function, helping restore the energy production capacity that daily life demands.
Brain Fog and Memory Issues
The cognitive dysfunction called brain fog affects concentration, memory, word-finding, and mental clarity. Difficulty concentrating is a common neurological symptom of long COVID that affects both children and adults, impacting work, school, and daily routines, and is often part of the cognitive impairment associated with the condition. Patients frequently report improvements in these neurological symptoms following EBOO treatment, likely reflecting reduced neuroinflammation and improved cerebral blood flow.
Post COVID brain fog appears connected to both direct viral effects on brain tissue and reduced oxygen delivery from microvascular dysfunction. EBOO’s combined filtration and oxygenation addresses both mechanisms simultaneously.
Shortness of Breath and Poor Circulation
Difficulty breathing persists for many patients despite normal lung imaging and pulmonary function tests. This disconnect often reflects microvascular obstruction rather than lung disease—the lungs work normally but oxygen cannot reach tissues efficiently due to circulation problems.
EBOO supports respiratory symptoms through microclot reduction and enhanced oxygen saturation. Patients frequently report improved exercise tolerance and reduced sensation of air hunger following treatment courses.
Autonomic Dysfunction and POTS Symptoms
Autonomic dysfunction POTS creates disabling symptoms including rapid heart rate upon standing, blood pressure instability, and temperature dysregulation. These manifestations reflect disrupted autonomic nervous system signaling affecting involuntary body functions.
Patients report improvements in heart rate variability and orthostatic tolerance following EBOO therapy. The mechanisms likely involve reduced inflammatory burden on autonomic pathways and improved oxygen delivery to neural tissues.
Joint Pain, Muscle Aches and Neuropathy
Chronic inflammation in tissues creates persistent muscle pain, joint discomfort, and neuropathy symptoms that significantly impair quality of life. These other symptoms of long covid often respond poorly to conventional pain management approaches.
EBOO’s systemic anti-inflammatory effects help reduce inflammatory cytokines driving tissue pain. Improved microvascular flow supports nerve function restoration and healing of damaged tissues.
Who is a Candidate for EBOO for Post-Viral Recovery
Ideal candidates for EBOO therapy in long COVID Oklahoma City treatment typically meet several criteria based on clinical experience with post-viral recovery protocols.
Patients with moderate to severe symptoms persisting beyond six months after their covid infection often respond well to EBOO. Those with confirmed microclots or elevated inflammation markers via D-dimer or fibrinogen testing represent particularly good candidates. EBV reactivation confirmed through serology suggests additional benefit from EBOO’s antiviral properties.
Chronic fatigue after COVID that has not responded to conventional medical management, physical therapy, or lifestyle modifications may indicate appropriateness for EBOO evaluation. Mitochondrial dysfunction indicated by low ATP markers or clinical presentation consistent with cellular energy deficits also suggests candidacy.
Contraindications include acute medical instability, G6PD deficiency, and certain blood disorders. Pre-treatment evaluation includes comprehensive health history review, assessment of underlying health conditions, and specific laboratory testing. We coordinate with your existing healthcare providers to ensure integrated care.
Medical history and symptom assessment help determine optimal treatment protocols. Lab work including inflammatory markers, coagulation studies, and viral serology establishes baseline values for tracking progress. This thorough evaluation ensures patient safety and treatment appropriateness.
What to Expect During and After Treatment
The treatment room environment at Venturis prioritizes patient comfort throughout the 45-60 minute session. You’ll recline comfortably while IV access is established and monitored for hemodynamic stability. Many patients read, rest, or listen to music during treatment.
During the oxygenation phase, mild warmth or tingling sensations are common and expected. These reflect enhanced circulation and ozone effects—most patients find them pleasant rather than concerning. Clinical staff monitors you throughout the session.
Immediate post-treatment, most patients feel good to resume normal activities. We recommend hydration and rest for the remainder of the treatment day. Some patients experience temporary detox reactions including mild fatigue or headache as inflammatory debris is processed and eliminated.
Cumulative benefits typically emerge over 6-12 sessions spaced weekly. Patients report gradual energy gains, cognitive improvement, and symptom attenuation with consistent treatment. Follow-up care includes regular biomarker monitoring and functional assessment to track progress objectively.
Living with Long COVID: Navigating Daily Life and Recovery
Living with long COVID presents unique challenges that can deeply affect daily life, work, and relationships. People with long COVID often experience a wide spectrum of long COVID symptoms—ranging from persistent fatigue and brain fog to chest pain, difficulty breathing, and post exertional malaise. These symptoms of long COVID can fluctuate in intensity, making it difficult to predict how you’ll feel from one day to the next. For many, even simple physical or mental activity can trigger a worsening of symptoms, impacting their ability to work, care for family, or participate in social activities.
The impact of post COVID conditions extends beyond physical health. Many individuals find that long haul COVID affects their mental and emotional well-being, leading to feelings of isolation or frustration. Support groups and online long COVID community resources can provide much-needed connection and understanding, helping people navigate the emotional aspects of this infection associated chronic condition.
Certain risk factors increase the likelihood that people develop long COVID. These include experiencing severe illness during the initial COVID-19 infection, having underlying health conditions such as heart disease or lung disease, and being of older age. Health and Human Services agencies and public health organizations like the World Health Organization are actively researching these risk factors to better identify and support higher risk individuals.
Diagnosing long COVID can be complex, as its symptoms often overlap with other medical conditions. Healthcare providers rely on a combination of health history, physical examination, and targeted lab tests to diagnose long COVID and rule out other causes. Disease control measures—such as vaccination, mask-wearing, and infection control—remain essential to prevent long COVID by reducing the risk of COVID-19 infection in the first place.
Managing long COVID requires a comprehensive, individualized approach. Healthcare providers may recommend physical therapy to address mobility and strength, occupational therapy to support daily functioning, and psychological support to help manage the emotional toll. National Institutes and other research organizations are conducting clinical trials to better understand long COVID and develop new long COVID treatment options. In the meantime, pacing and prioritizing activities can help reduce fatigue and post exertional malaise, while lifestyle modifications and symptom tracking can empower individuals to manage their health problems more effectively.
It’s important to recognize that long COVID is a serious public health concern. Public health officials, healthcare providers, and advocacy groups are working together to raise awareness, improve disease control, and ensure that people with long COVID have access to the resources and support they need. Legal protections under the Disabilities Act may also be available for those whose persistent symptoms significantly impact daily life.
Other symptoms of long COVID can include stomach pain, headaches, joint pain, and even complications like blood clots or heart disease. If you experience persistent symptoms after a COVID-19 infection, seek medical attention to determine if you may have long COVID. Early intervention and coordinated care can help manage symptoms and prevent complications.
For more about long COVID—including common symptoms, risk factors, diagnosis, and prevention—visit trusted health organizations such as the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO). Your primary care physicians and specialists can also provide guidance tailored to your health history and needs.
Remember, managing long COVID is a journey that often requires medical treatment, lifestyle adjustments, and emotional support. By seeking care, connecting with support groups, and staying informed about new research and treatment options, people with long COVID can take proactive steps toward improving their quality of life and navigating the challenges of this ongoing systemic disease state.
Supportive Therapies Added at Venturis
Comprehensive post-viral recovery often benefits from multiple complementary approaches addressing different aspects of the underlying dysfunction.
NAD+ Restoration
NAD+ deficiency appears common in long COVID patients, contributing to cellular energy deficits and metabolic dysfunction. IV NAD+ precursor therapy helps rebuild cellular energy capacity, supporting mitochondrial function and recovery from chronic infection states.
IV Nutrient Infusions
Myers’ cocktail variants deliver essential coenzymes, vitamins, and minerals directly to circulation, bypassing potential absorption issues common in post-viral illness. These nutrients support immune function, energy production, and tissue healing.
Ozone + Photodynamic Therapy
Additional ozone therapy protocols combined with UV irradiation provide enhanced pathogen inactivation and immune modulation. These synergistic effects complement EBOO for patients requiring more intensive intervention.
Mitochondrial Support + Peptides
Targeted peptides like SS-31 address electron transport chain dysfunction directly. These mitochondrial support interventions help restore cellular energy production capacity at the fundamental level.
How We Measure Progress (Functional + Lab Biomarkers)
Objective measurement transforms the recovery experience from frustrating uncertainty into trackable progress. We employ multiple assessment methods to document improvement.
Functional assessments include 6-minute walk testing for exercise tolerance, orthostatic vital signs for POTS evaluation, and standardized cognitive testing for brain fog. These measures capture real-world functional capacity relevant to daily life.
Laboratory biomarkers tracked include hs-CRP for inflammation, D-dimer for coagulation abnormalities, EBV titers for viral reactivation, and cytokine panels (IL-6, IL-8) for immune status. Mitochondrial markers like citrate synthase activity help assess cellular energy function.
Quality-of-life scales like SF-36 provide standardized patient-reported outcome measures that capture symptom burden and functional limitation. Serial testing shows improvement trends that validate subjective experience with objective data.
Patient Success Observations (Compliant Outcomes Language)
Clinical experience with compliant patients undergoing 8-10 EBOO sessions plus supportive therapies shows encouraging patterns. Patients report 50-70% symptom reductions in fatigue and brain fog per self-reported scales, with improvements in daily function and quality of life.
Patients previously unable to work have reported regaining functional capacity following treatment courses, with microclot resolution confirmed by specialized imaging. Those with confirmed EBV reactivation frequently note improvements in joint pain and fatigue that had persisted despite conventional management.
Outcomes vary based on treatment compliance, baseline severity, and individual health factors. The long covid community benefits from hope grounded in evidence rather than miracle claims—measurable improvement in lab markers and functional capacity demonstrates that recovery support is possible and progress is trackable.
Our Clinical Experience and Credentials
Our clinical experience with post-viral syndrome treatment draws from European oxidative therapy protocols established since the 1980s. Board-certified regenerative medicine specialists trained in EBOO filtration systems bring expertise to each patient case.
We’ve monitored thousands of post-viral cases, aligning treatment approaches with emerging research from initiatives like the RECOVER clinical trials investigating biological drivers of long COVID. Continuing education ensures our protocols reflect current understanding of this serious public health concern.
Integration with conventional medical care remains fundamental to our approach. We coordinate with primary care physicians, specialists, and other health care providers to ensure comprehensive, consistent care. Your health history and ongoing symptoms guide personalized treatment planning.
Next Step — Request a Post-Viral Recovery Case Review
Your post-viral recovery case review involves comprehensive biomarker analysis and personalized EBOO candidacy assessment. We’ll review your medical history, current symptoms, previous treatments, and goals for recovery.
Consultations include thorough discussion of treatment options, expected timelines, and realistic outcome expectations. We’ll address your questions and concerns, helping you make informed decisions about whether EBOO therapy fits your situation.
Cost information and flexible payment plan options are discussed during consultation. Deposits apply toward treatment costs for those who proceed. Schedule your case review to learn more about long covid recovery support options available at Venturis.
Request Your Post-Viral Case Review Deposit applies to treatment. Flexible payment plans available.
Frequently Asked Questions
How does EBOO therapy help with Long COVID symptoms? EBOO supports recovery by filtering microclots and inflammatory proteins from the blood, oxygenating tissues to counter hypoxia, and modulating immune function. Patients frequently report improvements in fatigue, brain fog, and exercise tolerance following treatment.
How is Long COVID diagnosed? Long COVID diagnosis is based on a history of suspected or confirmed COVID-19 infection and by ruling out alternative diagnoses. There are currently no lab tests or imaging studies to make the diagnosis of long COVID. Healthcare providers should consider long COVID as a potential diagnosis if patients report symptoms consistent with long COVID. Early diagnostic criteria required a laboratory-confirmed COVID-19 infection, but this is no longer necessary. When long COVID is diagnosed, the doctor will ask about your history of COVID-19, when symptoms began, and their severity. Diagnosis may involve a physical exam and specific diagnostic tests depending on your symptoms. People with long COVID may need care within several clinical disciplines for long-term monitoring or intervention. Primary care physicians should provide the first assessment, with specialist referrals for more complex symptoms.
How do you treat Long COVID? To treat long COVID, it is important to work with a health care provider to develop a personalized treatment plan to manage your symptoms. Self-care strategies, pacing, and rest are recommended, especially for fatigue. People with post-exertional malaise may benefit from activity management with pacing. Long COVID can be persistent and affect daily activities, so ongoing support and symptom management are essential.
Is EBOO safe for people with post-viral fatigue or EBV? When properly screened, EBOO appears safe for post-viral conditions including EBV reactivation. Low-dose ozone demonstrates hormesis effects without genotoxicity. Contraindications like G6PD deficiency are identified during pre-treatment evaluation.
How soon do patients usually notice improvement? Many patients report initial improvements after 3-5 sessions, with benefits typically peaking around sessions 10-12. Individual responses vary based on symptom severity and treatment compliance.
What causes Long COVID to last so long? Persistent viral fragments, EBV reactivation, microclots, immune dysregulation, and mitochondrial dysfunction all contribute to ongoing symptoms. These drivers often escape detection by standard testing, perpetuating the illness cycle.
Does EBOO replace my current doctor or medications? EBOO complements rather than replaces conventional medical care. We coordinate with your existing providers through shared records and communication, ensuring integrated treatment approaches.
How many sessions does recovery typically take? Most treatment courses involve 3-6 sessions spaced weekly or every other week, though individual needs vary. Progress assessment guides treatment duration recommendations. Out of town patients may have a different schedule as well.
Do you coordinate care with primary care or specialists? Yes—coordination with your existing healthcare team is standard practice. Referrals and shared data ensure consistent, comprehensive care for your recovery journey.
You are not crazy. There is a biological reason for your symptoms. We can measure and monitor improvement.
Request Your Post-Viral Case Review Today